Regenerative Medical Technology Group Inc. (RMTG) — SEC Financial Statements & Analysis

Regenerative Medical Technology Group Inc. (RMTG) is a retail-retail stores, nec company. Regenerative Medical Technology Group Inc. trades on OTC as: RMTG. Regenerative Medical Technology Group Inc. (RMTG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, Regenerative Medical Technology Group Inc. carries a market cap of $608.34K, a P/E ratio of -0.06x, a P/B ratio of -0.02x, a P/S ratio of 0.06x, an enterprise value of $3.43M, and an EV/EBITDA multiple of 8.44x. On profitability, it posts a gross margin of 59.76%, an operating margin of 0.46%, a net margin of -99.74%, a Return on Equity (ROE) of 27.51%, and a Return on Assets (ROA) of -181.69%. Per share, it reports EPS of $-0.71, diluted EPS of $-0.71, free cash flow per share of $-0.04, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 199.74% year-over-year, net income growth of 119.39% year-over-year, and EPS growth of 108.02% year-over-year. On the balance sheet, it maintains a current ratio of 0.05x, a quick ratio of 0.03x, working capital of $-40.33M, a debt-to-equity ratio of -1.15x, a debt ratio of 7.71, an interest coverage ratio of 0.00x, free cash flow of $-582.33K (TTM), and net debt of $2.82M. Figures sourced from SEC EDGAR.

Market Cap

$608.34K

P/E TTM

-0.06x

EPS TTM

$-0.71

P/B TTM

-0.02x

ROE TTM

27.51%

ROA TTM

-181.69%

Debt To Equity

-1.15x

Free Cash Flow TTM

$-582.33K

Net Revenue TTM Growth 1Y

199.74%

Data as of 2026-06-30 · Source: SEC EDGAR